SIFI S.p.A.

Mar 18, 2025

SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis

Dec 16, 2024

SIFI provides updates on the UK and US regulatory pathways for AKANTIOR® in the treatment of acanthamoeba keratitis

May 31, 2024

SIFI receives positive CHMP opinion for AKANTIOR® (polihexanide 0.08%) in acanthamoeba keratitis

Feb 05, 2024

SIFI ANNOUNCES THE ESTABLISHMENT OF A JOINT VENTURE IN THE UNITED ARAB EMIRATES

Feb 01, 2021

SIFI Announces the Publication of its Phase I Study on Polihexanide in the British Journal of Ophthalmology

Jan 07, 2021

SIFI Launches SYNFO, A New Treatment For Dry Eye Disease

Nov 19, 2020

SIFI completes enrollment of the Phase III Study of polihexanide 0.08% for the treatment of Acanthamoeba keratitis